Sr. Research Associate, RNA Molecular Biology

Posted on May 31,


Company Summary:

FL70, Inc is one of the latest companies founded through Flagship Pioneering’s venture creation engine, where companies such as Moderna Therapeutics, Rubius Therapeutics, and Evelo Therapeutics were conceived and created. Since Flagship’s founding in 2000, the firm has originated and fostered the development of nearly 100 scientific ventures resulting in $19+ billion in aggregate value, 500+ issued patents, and more than 50 clinical trials for novel therapeutic agents. FL70 is integrating the latest developments in molecular biology and plant biology to create a new platform technology that enables adaptive, targeted, and sustainable solutions in agriculture.

Position Summary:

We are seeking a passionate, proactive, and detail-oriented Senior Research Associate/Associate scientist to join our team. You will have the unique opportunity to work with a group of passionate scientists and take an active role in building our proprietary technology platform. The position requires technical experience in RNA biology and molecular biology, with a strong emphasis on multitasking, critical thinking, and teamwork. The successful candidate is a scientifically motivated self-starter, able to thrive in a fast-paced entrepreneurial environment, and an integral part of a highly collaborative and interdisciplinary team. Excellent communication, record-keeping, and teamwork will be critical.

Key Responsibilities:

  • Work with a team of scientists to innovate, optimize and execute RNA design and RNA engineering for a variety of experiments.
  • Responsible for RNA production, RNA preparation, and RNA structural characterization.
  • Responsible for RNA NGS library preparation and sequencing on Nanopore and Illumina platforms
  • Ability to independently troubleshoot experiments, solve challenging problems and optimize existing SOPs.
  • Support the RNA workflow at the company.
  • Communicate results in written technical reports and oral presentations.

Minimum Qualifications:

  • B.S. or M.S. with 2-4+ years of professional laboratory experience in molecular biology, biochemistry, biological sciences, or related field.
  • Experience in molecular biology techniques, such as gel electrophoresis, PCR, and qPCR.
  • Strong expertise in molecular biology, RNA biology, or next-generation sequencing.
  • Experience in RNA biology and RNA techniques, such as in vitro transcription, RNA extraction, and RNA purification.
  • A strong self-starter, independent thinker, with strong attention to detail.
  • Excellent communication, record-keeping, and teamwork will be critical.

Preferred Qualifications

  • Proficiency in assay development and optimization of nucleic acid production, purification, and biophysical characterization.
  • Familiarity with high-throughput experimental design and analysis is a plus.
  • Experience with NGS techniques, library preparation, and data analysis is a plus.
  • Experience with RNA design, characterization, and engineering is a plus.
  • Experience with plant biology or plant systems is a plus.

More About Flagship Pioneering

We are creative optimists and we would love for you to consider joining our team!  See all our open opportunities across Flagship Pioneering’s Ecosystem!

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including:  Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO),  Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated.  Learn more about our Company Creation Model.

Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO.